US 8252923
Peptidomimetic protease inhibitors
granted A61KA61K38/07A61K38/08
Quick answer
US patent 8252923 (Peptidomimetic protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/07, A61K38/08, A61K38/095, A61K38/21